Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Merus Labs International, Inc. (MSLI) Starts Presentation at 25th Annual ROTH Conference

Merus Labs International is a specialty pharmaceutical company engaged in the acquisition and licensing of branded prescription pharmaceutical products. MSLI enhances the sale and distribution of these projects by the introduction of a focused marketing and promotion plan. MSLI focuses on the areas of urology/women’s health, anti-infective and wound care. The company’s products include Factive, Emselex/Enable, Vancocin and Collacare and Collexa. For more information, visit the company’s Web site:

Let us hear your thoughts below:

This year's annual ROTH Conference will take place at The Ritz Carlton located in Laguna Niguel, on March 17-12, 2013. Bringing together executives from more than 400 growth companies, the ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit
This entry was posted in ROTH Capital Partners Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *